-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Day One Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.6M, a 20.3% increase year-over-year.
- Day One Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $48M, a 35.8% increase year-over-year.
- Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.3M, a 44.4% increase from 2022.
- Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27.2M, a 105% increase from 2021.
- Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.3M, a 2433% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)